AEPCC is establishing a Clinical Trials and Translation Network, Clinical Quality Registry and Lived Experience Network.
Collaboration will be key across the three programs, which all share the aim of improving the lives of young people experiencing psychosis.
The Clinical Trials and Translation Network (CTTN) will be the first Australian clinical trials network in youth mental health and early psychosis.
The CTTN will endorse large-scale, high-quality research, and support the translation of results into clinical practice – improving care for young people experiencing psychosis.
The Clinical Quality Registry (CQR) will work with early psychosis services across Australia to collect select demographic and clinical outcome data for young people receiving treatment for psychosis at their services.
Analysing data collected through the CQR will provide greater insight into treatment, care, and symptoms related to early psychosis, hopefully leading to improved outcomes for consumers.
The Lived Experience Network (LEN) will connect early and emerging psychosis service users from across Australia.
LEN members will come together to ensure the voice of people with lived experience of psychosis is central to AEPCC’s leadership and decision-making.